TISOTUMAB VEDOTIN
UNII T41737F88A

Substance Identification & Data

This profile provides standardized clinical and technical data for Tisotumab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T41737F88A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1418731-10-8 and the RxNorm Concept ID (RxCUI) 2571094. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T41737F88A

CAS Registry Number

1418731-10-8

RxNorm Concept ID

2571094

Detailed Substance Profile

Preferred Name

TISOTUMAB VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

T41737F88A

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C113164

National Cancer Institute reference terminology for clinical and research data.

INN ID

10148

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-177

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tisotumab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TISOTUMAB VEDOTIN

TISOTUMAB VEDOTIN-TFTV

Common Names & Synonyms

HUMAXTFADC

IMMUNOGLOBULIN G1, ANTI-(HUMAN BLOOD-COAGULATION FACTOR III) (HUMAN MONOCLONAL HUMAX-TF HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUMAX-TF .KAPPA.-CHAIN, DIMER, TETRAKIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

TISOTUMAB VEDOTIN [INN]

TISOTUMAB VEDOTIN [JAN]

TISOTUMAB VEDOTIN [USAN]

TISOTUMAB VEDOTIN [WHO-DD]

TISOTUMAB VEDOTIN TFTV [WHO-DD]